Current Gastroenterology Reports

, Volume 3, Issue 1, pp 71–78 | Cite as

Extrahepatic manifestations of chronic viral hepatitis

  • Nikolaos T. Pyrsopoulos
  • K. Rajender Reddy
Article

Abstract

Hepatitis B (HBV) and C (HCV) viruses are well-recognized causes for chronic hepatitis, cirrhosis, and even for hepatocellular carcinoma. Apart from liver disease, these viral infections are known to be associated with a spectrum of extrahepatic manifestations. The prevalence of clinically significant extrahepatic manifestations is relatively low, but it can be associated with significant morbidity and even mortality. An awareness and recognition of these manifestations is of paramount importance in facilitating early diagnosis and in offering treatment. However, treatments are not necessarily effective, and patients may continue with disabling extrahepatic manifestations. Hepatitis B virus has been well recognized as causing a variety of manifestations that include skin rash, arthritis, arthralgia, glomerulonephritis, polyarteritis nodosa, and papular acrodermatitis. More recently, infection with hepatitis C virus has elicited considerable interest for its role in a spectrum of extrahepatic manifestations. Among the best-reported are cryoglobulinemia, glomerulonephritis, high titer of autoantibodies, idiopathic thrombocytopenic purpura, lichen planus, Mooren’s corneal ulcer, Sjögren’s syndrome, porphyria cutanea tarda, and necrotizing cutaneous vasculitis. The precise pathogenesis of these extrahepatic complications has not been determined, although the majority represent the clinical expression of autoimmune phenomena.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Laskus T, Radkowski M, Wang LF, et al.: Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative strand viral RNA in various tissues. Hepatology 1998, 28:1398–1404.PubMedCrossRefGoogle Scholar
  2. 2.
    Caputo R, Gelmetti C, Ermacora E, et al.: Gianotti-Crosti syndrome: a retrospective analysis of 308 cases. J Am Acad Dermatol 1992, 26:207–210.PubMedGoogle Scholar
  3. 3.
    Clark E, Kaplan BI: Endocardial, arterial, and other mesenchymal alterations associated with serum sickness in man. Arch Pathol 1937, 24:458.Google Scholar
  4. 4.
    Trepo CH, Thivolet J: Australia antigen,virus hepatitis and periarteritis nodosa. Presse Med 1970, 78:1575.PubMedGoogle Scholar
  5. 5.
    Cacoub P, Lunel Fabiani F, Du LTH: Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 1992, 16:605–606.Google Scholar
  6. 6.
    Guillevin L, Lhote F, Gayraud M, et al.: Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. Medicine 1996, 75:17–28.PubMedCrossRefGoogle Scholar
  7. 7.
    Guillevin L, Lhote F, Cohen, et al.: Polyarteritis nodosa related to hepatitis B virus: a prospective study of 41 patients. Medicine 1995, 74:238–253.PubMedCrossRefGoogle Scholar
  8. 8.
    Guillevin L, Lhote F, Sauvaget F, et al.: Treatment of polyarteritis nodosa related to hepatitis B virus with interferon alpha and plasma exchange. Ann Rheum Disease 1994, 53:334–337.CrossRefGoogle Scholar
  9. 9.
    Lam KC, Lai CL, Trepo CH, et al.: Deleterious effect of prednisolone in HbsAg-positive chronic active hepatitis. N Engl J Med 1981, 304:380–386.PubMedCrossRefGoogle Scholar
  10. 10.
    Pinto PC, Hu E, Bernestein-Singer M, et al.: Acute hepatic injury after withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer 1990, 65:878–884.PubMedCrossRefGoogle Scholar
  11. 11.
    Combes B, Shorey J, Baarrera A, et al.: Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 1971, 2:234.PubMedCrossRefGoogle Scholar
  12. 12.
    Takekoshi Y, Tanaka M, Shida N, et al.: Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children. Lancet 1978, 18:1065–1068.CrossRefGoogle Scholar
  13. 13.
    Brzosko WJ, Drawczynski R, Nazarewicz T, et al.: Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children. Lancet 1974, 2:477.PubMedCrossRefGoogle Scholar
  14. 14.
    Lai KN, Lai FM, Chan KW, et al.: The clinico-pathologic features of hepatitis B associated glomerulonephritis. QJM 1987, 63:323–333.PubMedGoogle Scholar
  15. 15.
    Lai FM, Lai KN, Tam JS, et al.: Primary glomerulonephritis with detectable glomerular hepatitis B virus antigens. Am J Surg Pathol 1994, 18:175–186.PubMedCrossRefGoogle Scholar
  16. 16.
    Ito H, Hattori S, Matsuda I, et al.: Hepatitis Be antigenmediated membranous glomerulonephritis. Lab Invest 1981, 44:214.PubMedGoogle Scholar
  17. 17.
    Takekoshi Y, Tanaka M, Miyakawa Y, et al.: Free ’small’ and IgG-associated ’large’ hepatitis B antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N Engl J Med 1979 12, 300:814–819.PubMedCrossRefGoogle Scholar
  18. 18.
    He XY, Fang LJ, Zhang YE, et al.: In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis. Pediatr Nephrol 1998, 12:117–120.PubMedCrossRefGoogle Scholar
  19. 19.
    Conjeevaram HS, Hoofnagle JH, Austin HA, et al.: Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 1995, 109:540–546. An important paper concerning the natural history of glomerulonephritis after treatment with IFN-a.PubMedCrossRefGoogle Scholar
  20. 20.
    Chung DR, Yang WS, Kim SB, et al.: Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon. Am J Nephrol 1997, 17:112–117. Observations on response to treatment in patients with chronic HBV infection and glomerulonephritis.PubMedGoogle Scholar
  21. 21.
    Quan A, Portale A, Foster S, Lavine J: Resolution of hepatitis B virus related membranoproliferative glomerulonephritis after orthotopic liver transplantation. Pediatr Nephrol 1995, 9:599–602.PubMedCrossRefGoogle Scholar
  22. 22.
    McMahon BJ, Alberts SR, Wainwright RB, et al.: Hepatitis B-related sequelae: prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 1990, 150:1051–1054.PubMedCrossRefGoogle Scholar
  23. 23.
    Lai KN, Li PK, Lui SF, et al.: Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991, 324:1457–1463.PubMedCrossRefGoogle Scholar
  24. 24.
    Lohr H, Goergen B, Weber W, et al.: Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: cellular immune reactions and response to interferon treatment. J Med Virol 1994, 44:330–335.PubMedCrossRefGoogle Scholar
  25. 25.
    McMurray R: Hepatitis C associated autoimmune disorders. Rheum Dis Clin North Am 1998, 24:353–374. Extensive review of various autoimmune manifestations in patients with chronic HCV infection.PubMedCrossRefGoogle Scholar
  26. 26.
    Pawlotsky JM, Ben Yahia M, Andre C, et al.: Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994, 19:841–848.PubMedGoogle Scholar
  27. 27.
    Czaja AJ: Extrahepatic immunologic features of chronic viral hepatitis. Dig Dis Sci 1997, 15:125–144. Excellent review of various autoimmune phenomena in patients with chronic HCV infection.Google Scholar
  28. 28.
    Mergener K, Michel G, Braun HB, et al.: Anti-GOR titers in chronic hepatitis C in relation to interferon therapy. J Hepatol 1992, 16:4A.CrossRefGoogle Scholar
  29. 29.
    Casato M, Taliani G, Pucilo, et al.: Cryoglobulinemia and hepatitis C virus. Lancet 1991, 337:1047–1048.PubMedCrossRefGoogle Scholar
  30. 30.
    Durand JM, Lefevre H: Cutaneous vasculitis and cryoglobulinemia type II associated with hepatitis C virus infection. Lancet 1991, 337:499–500.PubMedCrossRefGoogle Scholar
  31. 31.
    Dammacco F, Zorzoli I, Cerino A, et al.: Clonality and specificity of cryoglobulins associated with HCV: pathophysiological implications. J Hepatology 1998, 29:879–886.CrossRefGoogle Scholar
  32. 32.
    VanThielD, Fagiouoli S, Caraceni P, et al.: Cryoglobulinemia: a cause for negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease. J Hepatol 1995, 22:446–467.CrossRefGoogle Scholar
  33. 33.
    Zignego AL, Ferri C, Giannini, et al.: Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996, 124:31–34.PubMedGoogle Scholar
  34. 34.
    Lenzi M, Frisoni M, Mantovani V, et al.: Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood 1998, 91:2062–2066.PubMedGoogle Scholar
  35. 35.
    Misiani R, Bellavita P, Fenili D, et al.: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994 17, 330:751–756.PubMedCrossRefGoogle Scholar
  36. 36.
    D’Amico GD, Colasanti G, Ferrario F, et al.: Renal involvement in essential mixed cryoglobulinemia. Kidney Int 1989, 35:1004–1014.PubMedGoogle Scholar
  37. 37.
    Pham HP, Feray C, Samuel D, et al.: Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients. Kidney Int 1998, 54:1311–1319.PubMedCrossRefGoogle Scholar
  38. 38.
    Johnson RJ, Gretch DR, Couser WG, et al.: Hepatitis C virusassociated glomerulonephritis: effect of alpha-interferon therapy. Kidney Int 1994, 46:1700–1704.PubMedGoogle Scholar
  39. 39.
    Okada K, Takishita Y, Shimomura H, et al.: Detection of hepatitis C virus core protein in the glomeruli of patients with membranous glomerulonephritis. Clin Nephrol 1996, 45:71–76.PubMedGoogle Scholar
  40. 40.
    Stehman-Breen C, Alpers CE, Couser WG, et al.: Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol 1995, 44:141–147.PubMedGoogle Scholar
  41. 41.
    Pakula AS, Garden JM, Roth SI: Cryoglobulinemia and cutaneous leukocytoclastic vasculitis associated with hepatitis C virus infection. J Am Acad Dermatol 1993, 28:850–853.PubMedGoogle Scholar
  42. 42.
    Rebora A, Patri P, Rampini E, et al.: Erosive lichen planus and cirrhotic hepatitis. Ital Gen Rev Dermatol 1978, 15:123–131.PubMedGoogle Scholar
  43. 43.
    Mokni M, Rybojad M, Puppin D Jr, et al.: Lichen planus and hepatitis C virus. J Am Acad Dematol 1991, 24:792.Google Scholar
  44. 44.
    Roy KM, Bagg J: Hepatitis C and oral disease: a critical review. Oral Dis 1999, 5:270–277. Good review of the various extrahepatic manifestations in patients with chronic HCV that can be found in the oral cavity.PubMedCrossRefGoogle Scholar
  45. 45.
    Navas S, Bosch O, Castillo I, et al.: Porphyria cutanea tarda and hepatitis C and B viruses infection: a retrospective study. Hepatology 1995, 21:279–284.PubMedGoogle Scholar
  46. 46.
    Carson CW, Conn DL, Czaja AJ, et al.: Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993, 20:304–309.PubMedGoogle Scholar
  47. 47.
    Wilson SE, Lee WM, Murakami C, et al.: Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology 1994, 101:736–745.PubMedGoogle Scholar
  48. 48.
    Zignego AL, Ferri C, Giannini C, et al.: Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma: evidence for a pathogenetic role. Arch Virol 1997, 142:545–555.PubMedCrossRefGoogle Scholar
  49. 49.
    Mazzaro GS, Franzin F, Tulissi P, et al.: Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to interferon therapy. Cancer 1996, 77:2613. Important observations on the prevention of lymphomas in patients with chronic HCV.CrossRefGoogle Scholar
  50. 50.
    Pawlotsky JM, Yahia MB, Andre C, et al.: Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994, 19:841–848.PubMedCrossRefGoogle Scholar
  51. 51.
    Roti E, Minelli, Giuberti T, et al.: Multiple changes in thyroid function in patients with active HCV hepatitis treated with recombinant interferon-alpha. Am J Med 1996, 101:611–615.CrossRefGoogle Scholar
  52. 52.
    Mason AL, Lau JY, Hoang N, et al.: Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 29:328–333. Controversial but significant report on the association of HCV with diabetes mellitus.PubMedCrossRefGoogle Scholar
  53. 53.
    Caniatti LM, Tugnoli V, Eleopra R, et al.: Cryoglobulinemic neuropathy related to hepatitis C virus infection: clinical, laboratory and neurophysiological study. J Periph Nerv Syst 1996, 1:131–138.Google Scholar

Copyright information

© Current Science Inc 2001

Authors and Affiliations

  • Nikolaos T. Pyrsopoulos
    • 1
  • K. Rajender Reddy
    • 1
  1. 1.Division of Hepatology, Center for Liver DiseasesUniversity of Miami School of MedicineMiamiUSA

Personalised recommendations